Jefferies Analysts Hot for Hologic (HOLX)
Tweet Send to a Friend
Get Alerts HOLX Hot Sheet
Price: $21.09 +1.05%
Rating Summary:
16 Buy, 6 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 35 | New: 23
Rating Summary:
16 Buy, 6 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 35 | New: 23
Trade HOLX Now!
With favorable financing all but secured, a deep dive into Hologic’s (Nasdaq: HOLX) pending Gen-Probe (Nasdaq: GPRO) deal suggests a combined 2.68 EPS, and this has analysts at Jefferies throwing around adjectives like 'exceedingly attractive'.
In the world of analyst-speak, descriptions like 'exceedingly attractive' are akin to words a fledgling rock star might utter the first time he gets his hands on a vintage Fender Telecaster, or maybe a groupie.
'With the revenue and cost synergies in the combined company, the favorable financing terms that seem to be coming into focus, and the aggressive deleveraging potential in the model, the biggest risk to the Hologic story is simply execution," notes Raj Denhoy, equity strategist.
Jefferies has a Buy rating on Hologic with a $24 price target.
For an analyst ratings summary and ratings history on Hologic click here. For more ratings news on Hologic click here.
Shares of Hologic closed at $17.28 yesterday, with a 52 week range of $13.90-$22.16.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
In the world of analyst-speak, descriptions like 'exceedingly attractive' are akin to words a fledgling rock star might utter the first time he gets his hands on a vintage Fender Telecaster, or maybe a groupie.
'With the revenue and cost synergies in the combined company, the favorable financing terms that seem to be coming into focus, and the aggressive deleveraging potential in the model, the biggest risk to the Hologic story is simply execution," notes Raj Denhoy, equity strategist.
Jefferies has a Buy rating on Hologic with a $24 price target.
For an analyst ratings summary and ratings history on Hologic click here. For more ratings news on Hologic click here.
Shares of Hologic closed at $17.28 yesterday, with a 52 week range of $13.90-$22.16.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Morgan Stanley Says Tesla (TSLA) 'Top Pick in U.S. Autos'
- UPDATE: Macquarie Downgrades Barrick Gold (ABX) to Underperform
- UPDATE: Leerink Swann Upgrades Bristol-Myers Squibb Co. (BMY) to Outperform
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS ViewRelated Entities
Jefferies & Co
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
